These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 819792)

  • 21. [Possibilites of thrombolytic treatment in arterial occlusions (author's transl)].
    Puchmayer V
    Cas Lek Cesk; 1977 Jul; 116(26):824-6. PubMed ID: 902286
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical use of thrombolytic agents].
    Laprevote-Heully MC; Lambert H; Larcan A
    Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters.
    Lonsdale RJ; Heptinstall S; Westby JC; Berridge DC; Wenham PW; Hopkinson BR; Makin GS
    Thromb Haemost; 1993 Feb; 69(2):103-11, 123. PubMed ID: 8456421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)].
    Schütz RM; Teufel W; Glocke M
    Med Klin; 1976 Sep; 71(39):1605-10. PubMed ID: 790128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of iliac artery stenosis with low dose streptokinase (author's transl)].
    Bopp J; Martin M; Büchner U; Auel H
    Dtsch Med Wochenschr; 1977 Feb; 102(6):198-201. PubMed ID: 137806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
    Traumann KJ
    Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experiences with arwin in combination with thrombolytic therapy].
    Keil-Kuri E; Hess H
    Verh Dtsch Ges Inn Med; 1974; 80():1470-2. PubMed ID: 4454460
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolytic therapy in arteriosclerotic disease (authors transl)].
    Denck H; Fischer M; Olbert F; Falkensammer C; Gauss P; Jonas M
    Wien Klin Wochenschr; 1975 Sep; 87(17):550-6. PubMed ID: 1189453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute arterial occlusive syndrome in streptokinase treatment of deep venous thrombosis--successful therapy with urokinase].
    Franke D; Lutze G; Presser HJ; Grüngreiff K
    Z Gesamte Inn Med; 1987 Jun; 42(12):343-6. PubMed ID: 3630281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic guidelines in diabetes.
    Sharma GV; Mukerjee DK; Sasahara AA
    Geriatrics; 1982 Apr; 37(4):38-42, 46. PubMed ID: 7060947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ancrod as prophylaxis or treatment for thromboembolism in patients with multiple trauma.
    Cole CW; Shea B; Bormanis J
    Can J Surg; 1995 Jun; 38(3):249-54. PubMed ID: 7788603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of local thrombolysis with special reference to diabetic metabolism].
    Stiegler H; Hufen V; Weichenhain B; Standl E; Mehnert H
    Med Klin (Munich); 1990 Apr; 85(4):171-5, 228. PubMed ID: 2352521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Incidence of peptic ulcer in an inpatient angiologic patient sample].
    Creutzig A; Horstkotte H; Fischer M; Kleine P; Brunner G; Alexander K
    Leber Magen Darm; 1984 Jul; 14(4):161-3. PubMed ID: 6482641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic thrombolysis of arterial occlusions of the lower extremities. Comparison of various treatment schedules].
    Lämmle B; Noll G; Christe M; Fritschi J; Czendlik C; Marbet GA; Biland L; Da Silva A; Huber P; Widmer LK
    Schweiz Med Wochenschr; 1983 Oct; 113(43):1570-6. PubMed ID: 6227992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urokinase in acute and chronic arterial diseases].
    Ciammaichella A; Gori M; Bonacci I
    Clin Ter; 1981 Nov; 99(4):377-81. PubMed ID: 7030591
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
    Forbes CD; Barbenell J; Prentice CR
    Haemostasis; 1976; 5(6):348-54. PubMed ID: 1017726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment possibilities of arterial circulatory disorders using calcitonin].
    Staehelin A
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1865-7. PubMed ID: 337477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
    Kellner H
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1399-1402. PubMed ID: 825745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.